Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research labs around the world.


TSXV:NSCI - Post by User

Comment by Fredo51545on May 01, 2022 4:48pm
103 Views
Post# 34646264

RE:Nanalysis 2021 Q4 Conference Call Notes and My Commentary

RE:Nanalysis 2021 Q4 Conference Call Notes and My CommentaryWell done review. If only $32 mil in 2023 rev including $9 mill from K-Prime, sales only grow 44% organically or $7 million. That is an awfully small increment given the size of the market they are targeting. Frankly, I am puzzled by this. I wonder if Magritek is growing faster? I am using revenue of $35.5 million, with a $7.6 million !Q. Agressive but doable within the confines of their manufacturing capacity. 
<< Previous
Bullboard Posts
Next >>